Frey, Sharon E <br/><br/>
Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects.  [electronic resource] 

 -  Vaccine  Sep 2014 
 - 5027-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2014.07.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Aged<br/>Antibodies, Viral--blood<br/>Antibody Formation<br/>Female<br/>Hemagglutination Inhibition Tests<br/>Humans<br/>Influenza A Virus, H3N2 Subtype<br/>Influenza Vaccines--immunology<br/>Influenza, Human--prevention & control<br/>Male<br/>Polysorbates--pharmacology<br/>Single-Blind Method<br/>Squalene--pharmacology<br/>Vaccine Potency